The anti-cancer treatment Yescarta was recently approved by the U.S. Food and Drug Administration as a treatment for lymphoma. It’s part of a new approach to combatting blood cancers by re-engineering the immune system.
Karen Weintraub from member station WBUR reports.
Copyright 2017 NPR. To see more, visit http://www.npr.org/.![](https://www.google-analytics.com/__utm.gif?utmac=UA-5828686-4&utmdt=New+Treatment+For+Lymphoma+Shows+Promise&utme=8(APIKey)9(MDAxODcyMTgzMDEyMTgxMTY5NjYxN2I4OQ004))
![](https://www.google-analytics.com/__utm.gif?utmac=UA-5828686-4&utmdt=New+Treatment+For+Lymphoma+Shows+Promise&utme=8(APIKey)9(MDAxODcyMTgzMDEyMTgxMTY5NjYxN2I4OQ004))
300x250 Ad
300x250 Ad